Diabetes mellitus is a problem more and more people suffer from nowadays. There are two main types of diabetes – type 1 (when people’s bodies cannot produce enough insulin on their own) and type 2 ...

Dr. Hirsch answers the question: 'Pros and Cons of Different Insulin Types?' — -- Question:What are the pros and cons of various types of insulins? Answer:I don't think we should think of insulin ...

The US Food and Drug Administration has approved rapid-acting insulin lispro-aabc injection 100 and 200 units/mL (Lyumjev, Eli Lilly) for the treatment of adults with type 1 and type 2 diabetes. The ...

A century ago, type 1 diabetes was a death sentence. Children diagnosed rarely survived more than a year or two, wasting away as their bodies starved despite food. Then, in 1921, in a modest lab in ...

AT278 demonstrates significantly accelerated PK/PD profile compared to NovoRapid® and Humulin® R U-500 in people with Type 2 Diabetes and high BMI Confirms previous trial results in people with Type 1 ...

The rising global diabetes burden, particularly Type 1 and Type 2, is a key driver for the rapid acting insulin market. As per the International Diabetes Federation, more than 530 million adults lived ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and children with diabetes, the agency announced Friday. Like its reference ...

This transcript has been edited for clarity. Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm Dr Silvio Inzucchi. This is episode number 6, and we've saved the best for last. We'll be ...

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with ...

Inhaled insulin uptake has been slow since its FDA approval due in part to a lack of awareness among adults with diabetes. The ongoing INHALE-1 study may help inhaled insulin earn FDA approval for ...

The FDA is on a roll. Fresh off handing down an approval to Medtronic’s latest insulin pump, the agency has doled out a nod for yet another diabetes device, this time to Insulet. In contrast to ...